Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D09YRA
|
||||
| Former ID |
DNCL003730
|
||||
| Drug Name |
SSTarbaclofen
|
||||
| Company |
Seaside Therapeutics; Roche
|
||||
| Target and Pathway | |||||
| Target(s) | GABA B receptor | Target Info | Modulator | ||
| References | |||||
| Ref 523344 | ClinicalTrials.gov (NCT01288716) Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders. U.S. National Institutes of Health. | ||||
| Ref 550082 | Effects of STX209 (Arbaclofen) on Neurobehavioral Function in Children and Adults with Fragile X Syndrome: A Randomized, Controlled, Phase 2 Trial. Science Translational Medicine Vol 4, Issue 152 19 September 2012. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.